ctrl K

Apogee Therapeutics Inc. (APGE)

NASDAQ: APGE · Real-Time Price · USD

39.26

0.01 (0.03%)

At close: May 01, 2025, 3:59 PM

39.20

-0.15%

Pre-market: May 02, 2025, 06:20 AM EDT

Apogee Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-216.87M	-93M	-30.73M
Interest Income	n/a	9.02M	92K
Pretax Income	-18K	-83.98M	-39.78M
Net Income	n/a	-83.98M	-39.78M
Selling & General & Admin	49.01M	24.58M	2.94M
Research & Development	167.87M	68.42M	27.79M
Other Expenses	n/a	n/a	n/a
Operating Expenses	216.87M	93M	30.73M
Interest Expense	n/a	n/a	9.15M
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	n/a	93M	30.73M
Income Tax Expense	-18K	n/a	-33.52K
Shares Outstanding (Basic)	55.19M	50.66M	50.67M
Shares Outstanding (Diluted)	55.19M	50.66M	50.67M
EPS (Basic)	n/a	-1.66	-0.79
EPS (Diluted)	n/a	-1.66	-0.79
EBITDA	-216.87M	-83.98M	n/a
EBIT	n/a	-83.98M	-39.78M
Depreciation & Amortization	n/a	9.02M	33.52M